Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study
- PMID: 11408299
- PMCID: PMC32306
- DOI: 10.1136/bmj.322.7300.1447
Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study
Abstract
Objective: To examine the relation of midlife raised blood pressure and serum cholesterol concentrations to Alzheimer's disease in later life.
Design: Prospective, population based study.
Setting: Populations of Kuopio and Joensuu, eastern Finland.
Participants: Participants were derived from random, population based samples previously studied in a survey carried out in 1972, 1977, 1982, or 1987. After an average of 21 years' follow up, a total of 1449 (73%) participants aged 65-79 took part in the re-examination in 1998.
Main outcome measures: Midlife blood pressure and cholesterol concentrations and development of Alzheimer's disease in later life.
Results: People with raised systolic blood pressure (>/=160 mm Hg) or high serum cholesterol concentration (>/=6.5 mmol/l) in midlife had a significantly higher risk of Alzheimer's disease in later life, even after adjustment for age, body mass index, education, vascular events, smoking status, and alcohol consumption, than those with normal systolic blood pressure (odds ratio 2.3, 95% confidence interval 1.0 to 5.5) or serum cholesterol (odds ratio 2.1, 1.0 to 4.4). Participants with both of these risk factors in midlife had a significantly higher risk of developing Alzheimer's disease than those with either of the risk factors alone (odds ratio 3.5, 1.6 to 7.9). Diastolic blood pressure in midlife had no significant effect on the risk of Alzheimer's disease.
Conclusion: Raised systolic blood pressure and high serum cholesterol concentration, and in particular the combination of these risks, in midlife increase the risk of Alzheimer's disease in later life.
Similar articles
-
Apolipoprotein E epsilon4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease.Ann Intern Med. 2002 Aug 6;137(3):149-55. doi: 10.7326/0003-4819-137-3-200208060-00006. Ann Intern Med. 2002. PMID: 12160362
-
Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease.Arch Neurol. 2005 Oct;62(10):1556-60. doi: 10.1001/archneur.62.10.1556. Arch Neurol. 2005. PMID: 16216938
-
Serum cholesterol changes after midlife and late-life cognition: twenty-one-year follow-up study.Neurology. 2007 Mar 6;68(10):751-6. doi: 10.1212/01.wnl.0000256368.57375.b7. Neurology. 2007. PMID: 17339582
-
Midlife Hypertension and Alzheimer's Disease: A Systematic Review and Meta-Analysis.J Alzheimers Dis. 2019;71(1):307-316. doi: 10.3233/JAD-190474. J Alzheimers Dis. 2019. PMID: 31381518
-
Hypertension and hypercholesterolaemia as risk factors for Alzheimer's disease: potential for pharmacological intervention.CNS Drugs. 2002;16(7):435-44. doi: 10.2165/00023210-200216070-00001. CNS Drugs. 2002. PMID: 12056919 Review.
Cited by
-
Healthy young hearts sharper older minds make.Ann Neurol. 2013 Feb;73(2):151-2. doi: 10.1002/ana.23847. Ann Neurol. 2013. PMID: 23526555 Free PMC article. No abstract available.
-
Peripheral inflammatory biomarkers predict the deposition and progression of amyloid-β in cognitively unimpaired older adults.Brain Behav Immun. 2021 Jul;95:178-189. doi: 10.1016/j.bbi.2021.03.015. Epub 2021 Mar 15. Brain Behav Immun. 2021. PMID: 33737171 Free PMC article.
-
Heart disease as a risk factor for dementia.Clin Epidemiol. 2013 Apr 26;5:135-45. doi: 10.2147/CLEP.S30621. Print 2013. Clin Epidemiol. 2013. PMID: 23658499 Free PMC article.
-
Cognitive reserve and midlife vascular risk: Cognitive and clinical outcomes.Ann Clin Transl Neurol. 2020 Aug;7(8):1307-1317. doi: 10.1002/acn3.51120. Epub 2020 Jul 21. Ann Clin Transl Neurol. 2020. PMID: 32856790 Free PMC article.
-
Lipid insertion domain unfolding regulates protein orientational transition behavior in a lipid bilayer.Biophys Chem. 2015 Nov;206:22-39. doi: 10.1016/j.bpc.2015.06.011. Epub 2015 Jul 4. Biophys Chem. 2015. PMID: 26164502 Free PMC article.
References
-
- Skoog I, Lernfelt B, Landahl S, Palmertz B, Andreasson L-A, Nilsson L, et al. 15-year longitudinal study of blood pressure and dementia. Lancet. 1996;347:1141–1145. - PubMed
-
- Launer LJ, Ross GW, Petrovitch H, Masaki K, Foley D, White LR, et al. Midlife blood pressure and dementia: the Honolulu-Asia aging study. Neurobiol Aging. 2000;21:49–55. - PubMed
-
- Notkola I-L, Sulkava R, Pekkanen J, Erkinjuntti T, Ehnholm C, Kivinen P, et al. Serum total cholesterol, apolipoprotein E4, and Alzheimer's disease. Neuroepidemiology. 1998;17:14–20. - PubMed
-
- Braak E, Griffing K, Arai K, Bohl J, Bratzke H, Braak H. Neuropathology of Alzheimer's disease: what is new since A. Alzheimer? Eur Arch Psychiatry Clin Neurosci. 1999;249(suppl 3):14–22. - PubMed
-
- Vartiainen E, Puska P, Jousilahti P, Korhonen HJ, Tuomilehto J, Nissinen A. Twenty-year trends in coronary risk factors in North-Karelia and in other areas of Finland. Int J Epidemiol. 1994;23:495–504. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical